A Prospective Study of Hypofractionated Proton Beam Therapy for Patients With Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 3, 2009, Pages 831-836

  Fukumitsu, Nobuyoshi ^a,b   Sugahara, Shinji ^a,b   Nakayama, Hidetsugu ^a,b   Fukuda, Kuniaki ^a   Mizumoto, Masashi ^a,b   Abei, Masato ^a   Shoda, Junichi ^a   Thono, Eriko ^a   Tsuboi, Koji ^a,b   Tokuuye, Koichi ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Proton beam therapy; Radiotherapy

Indexed keywords

AFTER-TREATMENT; FETOPROTEIN; GASTROINTESTINAL TRACT; HEPATOCELLULAR CARCINOMA; LOCAL CONTROL; OVERALL SURVIVAL RATES; POST TREATMENT; PRE-TREATMENT; PROSPECTIVE STUDY; PROTON BEAM THERAPY;

PROTON BEAMS; RADIOTHERAPY;

PROTONS;

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTON THERAPY; RADIATION DOSE;

AGED; ALPHA-FETOPROTEINS; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; DOSE FRACTIONATION; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LIVER; LIVER NEOPLASMS; MALE; PROSPECTIVE STUDIES; PROTONS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 67049145223     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.073     Document Type: Article

References (36)

1. McGlynn K.A., and London W.T. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19 (2005) 3-23
2. Bosch F.X., Ribes J., and Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 19 (1999) 271-285
3. Okuda K., Ohtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients. Cancer 56 (1985) 918-928
4. El-Domeiri A.A., Huvos A.G., Goldsmith H.S., et al. Primary malignant tumors of the liver. Cancer 27 (1971) 7-11
5. Nagasue N., Yukaya H., Hamada T., et al. The natural history of hepatocellular carcinoma: A study of 100 untreated cases. Cancer 54 (1984) 1461-1465
6. Ikai I., Arii S., Ichida T., Okita K., et al. Report of the 16th follow-up survey of primary liver cancer. Hepatol Res 32 (2005) 163-172
7. Molinari M., Kachura J.R., Dixon E., et al. Transarterial chemoembolisation for advanced hepatocellular carcinoma: Results from a North American cancer centre. Clin Oncol 18 (2006) 684-692
8. Guan Y.S., and Liu Y. Interventional treatments for hepatocellular carcinoma. Hepatobil Pancreat Dis Int 5 (2006) 495-500
9. Takayasu K., Arii S., Ikai I., et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131 (2006) 461-469
10. Shimada K., Sakamoto Y., Esaki M., et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 14 (2007) 2337-2347
11. Itamoto T., Nakahara H., Amano H., et al. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 141 (2007) 589-597
12. Ohmoto K., Yoshioka N., Tomiyama Y., et al. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: A retrospective comparative study. Hepatogastroenterology 54 (2007) 985-989
13. Choi D., Lim H.K., Rhim H., et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: Long-term results and prognostic factors in a large single-institution series. Eur Radiol 17 (2007) 684-692
14. Yeo W., Mok T.S., Zee B., et al. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst 97 (2005) 1532-1538
15. Suit H., and Urie M. Proton beams in radiation therapy. J Natl Cancer Inst 84 (1992) 155-164
16. Chiba T., Tokuuye K., Matsuzaki Y., et al. Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients. Clin Cancer Res 15 11 (2005) 3799-3805
17. Hata M., Tokuuye K., Sugahara S., et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 104 (2005) 794-801
18. Hashimoto T., Tokuuye K., Fukumitsu N., et al. Repeated proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 196-202
19. Hata M., Tokuuye K., Sugahara S., et al. Proton beam therapy for hepatocellular carcinoma with limited treatment options. Cancer 107 (2006) 591-958
20. Hata M., Tokuuye K., Sugahara S., et al. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis. Strahlenther Onkol 182 (2006) 713-720
21. Hata M., Tokuuye K., Sugahara S., et al. Proton beam therapy for aged patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 69 (2007) 805-812
22. Nohtomi A., Sakae T., Tsunashima Y., et al. Dosimetry of pulsed clinical proton beams by a small ionization chamber. Am Assoc Phys Med 28 (2001) 1431-1435
23. Tsunashima Y., Sakae T., Shioyama Y., et al. Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 951-958
24. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62 (1989) 679-694
25. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
26. Miller A.B., Hoogstraten B., Staquet B., et al. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
27. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
28. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35 (1977) 1-39
29. Cox D.R. Regression models and life tables. J Roy Stat Soc Sec B34 (1972) 187-220
30. Hosmer D.W., and Lemeshow S. Applied logistic regression. 2nd ed. (2000), Wiley, New York
31. Bush D.A., Hillebrand D.J., Slater J.M., et al. High-dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial. Gastroenterology 127 (2004) S189-S193
32. Kawashima M., Furuse J., Nishio T., et al. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 23 (2005) 1839-1846
33. Kato H., Tsujii H., Miyamoto T., et al. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 59 (2004) 1468-1476
34. Taketa K. Alpha-fetoprotein: re-evaluation in hepatology. Hepatology 12 (1990) 1420-1432
35. Brumm M.C., Schulze C., Charels K., et al. The significance of alpha fetoprotein and other tumor markers in differential immunohistochemistry of primary liver tumors. Histopathology 14 (1989) 503-513
36. Tangkijvanich P., Anulkulkarnkusol N., Suwangool P., et al. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on alpha-fetoprotein levels. J Clin Gastroenterol 1 (2000) 301-308